The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...
Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
Experts said millions of people across the country are prescribed a medicine for moderate to severe acute pain each year, so ...
The US Food and Drug Administration has approved suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
U.S. federal officials have approved a new pain pill aimed at preventing addiction and overdose risks linked to opioids like ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.